Dishman Carbogen Amcis Company Description
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide.
The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments.
It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics.
The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Country | India |
Founded | 1983 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 1,106 |
CEO | Arpit Vyas |
Contact Details
Address: Dishman Corporate House Ahmedabad, Gujarat 380058 India | |
Phone | 91 27 1742 0102 |
Website | imdcal.com |
Stock Details
Ticker Symbol | DCAL |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE385W01011 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Dr. Stephan Fritschi Ph.D. | Chief Executive Officer of CARBOGEN AMCIS |
Jayesh A. Shah | Chief Executive Officer of Production |
Dr. Himani S. Dhotre | Chief Executive Officer of Projects and Operations |
Arpit Janmejay Vyas | Global MD and Director |
Deohooti Janmejay Vyas | Whole Time Director |
Harshil R. Dalal | Global Chief Financial Officer |
Paolo Armanino | Chief Operating Officer of Indian Operations |
Shrima Gaurangbhai Dave | Compliance Officer and Company Secretary |
Dharmesh Desai | GM of Secretarial and Legal |
. Gavin | Head of ESH |